Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery

NARecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 5, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Oncologic SurgeryCancerCancer SurgeryHepatic CancerGastric (Cardia, Body) CancerBiliary Tract CancerPancreatic Cancer ResectableGynecologic CancersGastrointestinal CancersColorectal CancerMinimally Invasive Surgical Procedures
Interventions
PROCEDURE

Local Anesthesia

For local anesthetic administration at port sites, 30 mL of 0.1% ropivacaine is injected around the umbilical port site following the completion of the primary surgical procedure. Additionally, 5 mL of 0.1% ropivacaine is injected around each additional port site to ensure effective local anesthesia.

PROCEDURE

Laparoscopic Transversus Abdominis Plane block

Surgeon will place 18 gauge needle into the fascial plane between the internal oblique and transversus abdominis muscles. Once the needle is accurately positioned surgeon will inject 15 mL of 0.1% ropivacaine slowly. This procedure is performed bilaterally to ensure comprehensive analgesia. The total volume utilized for the LapTAP block is 30 mL of 0.1% ropivacaine.

Trial Locations (1)

15224

RECRUITING

AHN West Penn Hospital, Pittsburgh

All Listed Sponsors
lead

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

OTHER